Curet Myriam - Nov 10, 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Stock symbol
ISRG
Transactions as of
Nov 10, 2025
Transactions value $
-$34,714
Form type
4
Date filed
11/12/2025, 02:12 PM
Previous filing
Oct 29, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 2025-11-12 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $24.1K +105 $229.39 105 Nov 10, 2025 Direct F1
transaction ISRG Common Stock Sale -$58.8K -105 -100% $560.00 0 Nov 10, 2025 Direct F1
holding ISRG Common Stock 353 Nov 10, 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -105 -6.26% $0.00 1.57K Nov 10, 2025 Common Stock 105 $229.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.